作者

David Mulder

法律顾问

Read More

Christian Dekoninck

合伙人

Read More

Adrian Toutoungi

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr. Angela Knierim

授薪合伙人

Read More
作者

David Mulder

法律顾问

Read More

Christian Dekoninck

合伙人

Read More

Adrian Toutoungi

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr. Angela Knierim

授薪合伙人

Read More

2020年11月23日

Pharmaceutical patent law – 2 / 2 观点

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

  • Quick read

Which extraordinary regulations have been put in place for speeding up clinical trials in emergency situations like the current coronavirus pandemic? And how is early access to new medicines warranted under such circumstance?

The second part of the two-part series ‘Pharmaceutical Patent Law in Times of Crisis: A Comparative Study’, written for the European Intellectual Property Review by our international team, addresses these questions and more on both a broad, European level and from the perspective of six national jurisdictions.
 

Read the article here

本系列内容

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Biotech acquisition trend: radiopharmaceuticals

2024年5月8日
Briefing

作者 Adrian Toutoungi

点击此处了解更多
酒店与休闲

Early IP Strategy for Life Sciences Start-Ups Pays off

We explain the 5 biggest pitfalls

2024年3月22日
Briefing

作者 Dr. Anja Lunze, LL.M. 以及 Tobias Baus, LL.M., Dipl.-Ing.

点击此处了解更多
医疗器械

Artificial Intelligence (AI) in medical devices: The better the product, the harder the conformity assessment?

2023年10月27日
Briefing

作者 Dr. Angela Knierim

点击此处了解更多